Kymera Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $203.3M | $487.2M | $31.0M |
| FY2021 | $146.3M | $605.9M | $48.0M |
| FY2022 | $113.0M | $603.1M | $68.4M |
| FY2023 | $180.8M | $575.8M | $110.0M |
| FY2024 | $142.4M | $978.0M | $120.3M |